Picture of Dr. Shezad Malik

Xarelto Strokes & Gastro-Intestinal Bleeding Lawsuits

Xarelto (Rivaroxaban), a new blood-thinning medication, has been approved to prevent stroke in patients with heart rhythm problems known as atrial fibrillation. Xarelto is manufactured by Bayer and Johnson and Johnson pharmaceutical companies.

Xarelto Strokes & Gastro-Intestinal BleedingAccording to medical experts safety and effectiveness questions remain. Xarelto, is a potent new blood-thinning drug, has been linked to an increased risk of severe, life-threatening and in some instances fatal internal bleeding episodes.

Xarelto side effects have been linked to brain bleeds, hemorrhages, strokes, and stomach intestinal bleeding, among other injuries.

Lawsuits allege that drug-makers failed to warn that Xarelto lacks an effective reversal agent, which can make it difficult, if not impossible to stop bleeding in an emergency.

Many Xarelto injured patients are now filing lawsuits against the manufacturers nationwide.

Injured by Xarelto? Call Dr Shezad Malik Law Firm Are you looking for a Xarelto Brain Bleed or Gastro-Intestinal Bleeding Attorney in Texas?

Do You Live in Dallas, Fort Worth, Austin or Houston, and Want to File a Texas Xarelto Uncontrollable Bleeding Lawsuit?

As a result of the drug makers’ failure to adequately warn about the risks associated with the anticoagulant, financial compensation may be available through an Xarelto lawsuit for individuals who have experienced:

  • Internal Bleeding or Gastrointestinal Bleeding
  • Brain Hemorrhage
  • Intra-Cranial Bleed
  • Intra-Cerebral Bleed
  • Sub-Dural Hematoma
  • Hemorrhagic Stroke
  • Wrongful Death From Bleeding Problems
Dr. Shezad Malik Law Firm can Help - Call Us

The Dr Shezad Malik Law Firm is currently investigating and accepting Xarelto uncontrollable bleeding injury cases nationwide, including California, Florida, Illinois, New York and Texas.

We are accepting and evaluating Xarelto bleeding side effect cases including uncontrollable gastrointestinal bleeding (stomach, colon, rectum), brain bleeding (intracranial bleeding, intracerebral bleeding, sub-dural hematoma), uncontrollable bleeding from minor cuts/lacerations, slip and falls, minor trauma, bleeding episodes requiring hospitalizations, blood transfusions and death.

If you or somebody you know has been injured or died as a result of Xarelto bleeding, you should contact the Xarelto Injury Team attorneys at the Dr Malik Law Firm immediately for a free case consultation. Please use the contact form to contact us or call toll free 24 hours a day at (888) 210-9693 ext 2.

Xarelto Bleeding Risk Higher for Acutely Ill Patients

A medical study presented at the American Heart Association, in November 25, 2013, indicated Xarelto caused a 3-fold increased risk of bleeding for acutely ill patients and a 4-fold increased risk of major bleeding in patients with Acute Coronary Syndrome (ACS).

Der Spiegel in October 4, 2013, reported that Xarelto has been linked to 968 adverse events (including 72 deaths) during the first 8 months of 2013. In 2012, Xarelto was associated with 750 adverse events, including 58 deaths.

What is the Problem with Xarelto?

The U.S. Food and Drug Administration (FDA) approved Xarelto in July 2011 for a limited group of people, getting knee or hip replacement surgery, because they are at a higher risk of developing blood clots that could lead to a stroke, deep vein thrombosis or pulmonary embolism.

In November 2011, Xarelto was approved to prevent stroke in people with abnormal heart rhythm, also known as non-valvular atrial fibrillation. Atrial fibrillation leads to heart blood clots, which travels to the brain, causing a stroke.

Despite all the advertisements, Xarelto does cause more gastrointestinal bleeding than the standard therapy for blood clot prevention, Coumadin but more importantly there is no antidote for uncontrollable bleeding.

Coumadin bleeding side effects can be reversed with Vitamin K and blood transfusions.

Xarelto has NO APPROVED ANTIDOTE at this time. Higher Bleeding Risk in Xarelto Patients

An April 2011 medical study involving 8,000 people compared Xarelto to Lovenox (an injectable blood thinner) in patients hospitalized for heart failure, infectious disease and breathing difficulty medical conditions.

The study compared Xarelto to Lovenox used over 10 days, and found the two medications equally effective. Patients taking Xarelto for 35 days had significantly higher rates of bleeding, they were more than twice as likely to experience bleeding compared to Lovenox.

Xarelto “ROCKET” Safety Study

The biggest clinical trial of Xarelto evaluated more than 14,000 patients, and compared Xarelto to warfarin (older oral blood thinner drug). The study found that Xarelto was no more effective than warfarin, and the side effect risks were similar.

The most common side effect was bleeding, with rates similar to warfarin. It caused less bleeding in the brain and more bleeding in the stomach and intestines.

The safety and effectiveness of Xarelto has been questioned, after a report in the New England Journal of Medicine found that the use of multiple statistical analyses “muddied the waters.”

FDA reviewers who examined the data found that the drug-makers failed to administer warfarin in an optimal way, which may have skewed the data.

The reviewers recommended that an additional study is needed to clarify potential stroke and bleeding risks.

UK Agency Asks for More Xarelto Safety Data

Britain’s National Institute for Health and Clinical Excellence (NICE) is asking Bayer to provide more safety data before it can recommend the drug for use in the state health services.

NICE said that the data Bayer had already provided was not sufficient to determine safety or efficacy of Xarelto. Because of the lack of data, the organization decided not to recommend the drug.

New Anticoagulants Xarelto, Pradaxa, Eliquis, and Lixiana in a Race

There is a race to dominate the estimated $20 billion medical market place for these anti-stroke medications. Several major pharmaceutical companies tout the newer drugs as alternatives to warfarin, an older and cheaper blood-thinning medication.

Pfizer and Bristol-Myers Squibb, manufacturers Eliquis (apixaban). Boehringer Ingelheim manufacturers Pradaxa (dabigatran). Lixiana (edoxaban) is an oral anticoagulant drug in development by Daiichi Sankyo in Japan.

Injured by Xarelto? Contact Dr Shezad Malik Law Firm Now

If you or a loved one used Xarelto and have suffered injuries or wrongful death with the medication, contact the Xarelto Injury Team attorneys at Dr Shezad Malik Law Firm to learn more about your legal rights. You can speak with one of our team by calling toll-free at 888-210-9693, 214-390-3189 or by filling out the case evaluation form on this page.

Our law firm’s principal office is in Dallas and we have offices in Fort Worth, Texas. Dr Shezad Malik Law Firm represents clients in dangerous drug and dangerous medical device lawsuits nationwide.

Contact Us For a Free Consultation